Global biotechnology company Nona Biosciences announced on Thursday the appointment of Dr. Peng Wang as its new chief operating officer (COO).

Dr. Wang will be based in Suzhou and will report directly to Dr. Di Hong, chief executive officer of Nona Biosciences.

As COO, Dr. Wang will be responsible for establishing an efficient and integrated scientific research platform, rapidly building core technical capabilities, and upgrading the company's comprehensive and standardised scientific research service system. He will lead efforts to realise lean and efficient resource management, with a focus on elevating overall project management efficiency to support Nona's growing portfolio of partner programmes.

Dr. Wang brings over 15 years of extensive experience in biomedical research and drug development. Prior to joining Nona, he served as head of Biologics and in vitro APAC at Crown Bioscience. Before that, he held the position of head of Antibody Group at WuXi AppTec and served as a senior scientist at Roche.